Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
2.350
+0.100 (4.44%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Allurion Technologies Revenue
In the year 2024, Allurion Technologies had annual revenue of $32.11M, down -39.94%. Allurion Technologies had revenue of $5.59M in the quarter ending December 31, 2024, a decrease of -32.11%.
Revenue (ttm)
$32.11M
Revenue Growth
-39.94%
P/S Ratio
0.16
Revenue / Employee
$234,380
Employees
137
Market Cap
13.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32.11M | -21.36M | -39.94% |
Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
Dec 31, 2022 | 64.21M | 25.97M | 67.91% |
Dec 31, 2021 | 38.24M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALUR News
- 15 days ago - Allurion Announces Postponement of Special Meeting of Stockholders - Business Wire
- 23 days ago - Allurion Technologies Inc. (ALUR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - Business Wire
- 4 weeks ago - Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence - Business Wire
- 5 weeks ago - Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025 - Business Wire
- 6 weeks ago - Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity - Business Wire
- 7 weeks ago - Allurion to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Business Wire